The development of lhermitte's sign during cisplatin chemotherapy: Possible drug-induced toxicity causing spinal cord demyelination
- 1 November 1987
- Vol. 60 (9), 2170-2172
- https://doi.org/10.1002/1097-0142(19871101)60:9<2170::aid-cncr2820600909>3.0.co;2-n
Abstract
Cisplatin is a recognized neurotoxic agent that commonly causes ototoxicity and peripheral neuropathy. In conjunction with characteristic peripheral neuropathy, two patients treated with high-dose cisplatin developed Lhermitte's sign, a manifestation of posterior column spinal cord pathology. After cisplatin therapy was stopped, this symptom gradually resolved. This suggests that at high doses cisplatin may also cause demyelinating central nervous system lesions involving the spinal cord.This publication has 20 references indexed in Scilit:
- Delayed onset of Lhermitte's sign following head and/or neck injuriesJournal of Neurosurgery, 1984
- ?Lhermitte's sign? as a presenting symptom of subacute combined degeneration of the cordAnnals of Neurology, 1983
- Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- Transient radiation myelopathy (Lhermitte's sign) in patients with Hodgkin's disease treated by mantle irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum IIZeitschrift für Krebsforschung und Klinische Onkologie, 1980
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979
- Neuropathology of experimental vitamin B 12 deficiency in monkeysNeurology, 1976
- Lhermitte's sign in subacute combined degeneration of the cordJournal of Neurology, Neurosurgery & Psychiatry, 1973
- Lhermitte's phenomenon after high velocity missile injuries of the brainJournal of Neurosurgery, 1971
- CREUTZFELDT-JAKOB DISEASE; 1. Survey of The Literature and Clinical DiagnosisActa Neurologica Scandinavica, 1968